Cardiovascular disease – the silent killer in rheumatoid arthritis

Author： Kumar Namita   Armstrong David J  

Publisher： Royal College Of Physicians

ISSN： 1470-2118

Source： Clinical Medicine, Vol.8, Iss.4, 2008-08, pp. : 384-387

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rheumatoid Arthritis: Genetic Variants as Biomarkers of Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 21, Iss. 2, 2015-01 ,pp. : 182-201

Bentham Science Publishers

Access to resources Recommend Favorite

Rheumatoid Arthritis: An Autoimmune Disease with Female Preponderance and Cardiovascular Risk Equivalent to Diabetes Mellitus: Role of Cardiovascular Magnetic Resonance

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 2, 2014-01 ,pp. : 81-93

Bentham Science Publishers

Access to resources Recommend Favorite

Critical Determinants of Cardiovascular Risk in Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 17, Iss. 1, 2011-01 ,pp. : 21-26

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular Effects of Methotrexate in Rheumatoid Arthritis Revisited

By  

Current Medicinal Chemistry, Vol. 22, Iss. 16, 2015-05 ,pp. : 1903-1910

Bentham Science Publishers

Access to resources Recommend Favorite

Rheumatoid Arthritis: Cardiovascular Manifestations, Pathogenesis, and Therapy

By  

Current Pharmaceutical Design, Vol. 18, Iss. 11, 2012-04 ,pp. : 1450-1456

Bentham Science Publishers

Access to resources Recommend Favorite